Kyverna Therapeutics: Audience

Kyverna Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for patients suffering from autoimmune diseases. Their lead product, KYV-101, aims to provide long-term remission through CAR T-cell therapy.